Boulding Mark Elliott's Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed Jan 6, 2026
- Accession no.
- 0001578852-26-000002
- Filed
- Jan 6, 2026
- Trade date
- Jan 2-5, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $171.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Boulding Mark ElliottCIK 0001578852 | Officer (EXEC. VP AND CLO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Common Stock | AGrant or awardAcquired | +17,000 | $0.00 | $0 | 120,901 | Direct | |
| Jan 5, 2026 | Common Stock | MOption exerciseAcquired | +2,266 | $39.42 | +$89,325.72 | 123,167 | Direct | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −1,123 | $74.92F3 | −$84,135.16 | 122,044 | Direct | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −1,035 | $76.10F4 | −$78,763.5 | 121,009 | Direct | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −108 | $76.79F5 | −$8,293.32 | 120,901 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Common Stock | AGrant or awardAcquired | +42,500 | $0.00 | $0 | 42,500 | Direct | |
| Jan 5, 2026 | Common Stock | MOption exerciseDisposed | −2,266 | $0.00 | $0 | 9,063 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $74.55 to $75.27 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.58 to $76.42 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.75 to $76.81 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.